Login / Signup

Bicyclic Pyrrolidines for Medicinal Chemistry via [3 + 2]-Cycloaddition.

Vladimir I SavychVladimir L MykhalchukPavlo V MelnychukAndrii O IsakovTaras SavchukVadim M TimoshenkoSergiy A SirySergiy O PavlenkoDmytro V KovalenkoOleksandr V HryshchukVitalii A ReznikBohdan A ChalykVladimir S YarmolchukEduard B RusanovPavel K Mykhailiuk
Published in: The Journal of organic chemistry (2021)
A general approach to bicyclic fused pyrrolidines via [3 + 2]-cycloaddition between nonstabilized azomethyne ylide and endocyclic electron-deficient alkenes was elaborated. "Push-pull" alkenes and CF3-alkenes did not react with the azomethyne ylide under the previously reported conditions, and we developed a superior protocol (LiF, 140 °C, no solvent). Among obtained products were medchem-relevant bicyclic sulfones, monofluoro-, difluoro-, and trifluoromethyl-substituted pyrrolidines. This approach not only allowed preparation of novel molecules but also significantly simplified synthesis of the existing ones (e.g., sofinicline).
Keyphrases
  • cystic fibrosis
  • randomized controlled trial
  • molecular docking
  • solar cells
  • ionic liquid
  • molecularly imprinted
  • high resolution